On June 23, a federal court upheld the Trump Administration’s 2020 Price Transparency Rule, which would require hospitals to disclose their charges and payer-specific negotiated rates for all services they provide.

Yet, many questions remain regarding what provider executives need to do next to prepare for the rule, including:

• Is the rule settled and will there be an appeal?
• What does compliance with the rule look like and what are consequences of non-compliance?
• How might this affect hospital pricing strategies and overall market dynamics?
• Will COVID-19-related utilization changes impact price transparency?